Human Biology Division

Exploring Biological Systems to Find New Ways to Fight Cancer and Other Diseases

Grounded in high-quality science, researchers in the Human Biology Division perform fundamental, applied and translational research in model organisms and in vitro systems. With backgrounds in molecular and cell biology, genomics, genetics, virology, infectious disease, computational biology, pathology and clinical research, these investigators form an interdisciplinary team that in other institutions would likely be spread out over multiple departments. Together, they propel research toward new and improved approaches to the treatment and prevention of cancers and infectious diseases.

A group of research scientists.

Diverse Knowledge

Our faculty apply individual advances in human biology to their research into cancer and infectious diseases.

A research scientist dropping liquid into a petri dish.

Accelerating Advances

Our labs explore cancer and infectious diseases at a molecular and genetic level to discover new forms of treatment.

pull quote photo

“What drives me is making an impact in patients’ lives. Research is a continuous and intense process, not a short-term outcome.”

— Dr. Taran Gujral, cancer biologist

A Multidisciplinary Approach

Learn about our scientific leadership, job openings, upcoming events and seminars hosted by the Human Biology Research Team.

Read Our Faculty Members Latest Scientific Publications

Latest Human Biology News

All Human Biology news
RNA stability may play a role in prostate cancer New research links mutations in RNA region that helps regulate protein production to progression and drug resistance July 28, 2023
Dr. Sita Kugel receives V Foundation Translational Research Award Grant makes possible a clinical trial of targeted treatment for pancreatic cancer June 27, 2023
Brain cancer expert Dr. Eric Holland receives Endowed Chair in Cancer Biology Chair recognizes comprehensive vision, contributions to solid tumor research May 5, 2023
Improving immunotherapy for advanced prostate cancer Preclinical work identifies better target and recruits more immune cells to make CAR-T therapy work for solid tumors April 27, 2023